Is Aspirin monotherapy effective for stroke prevention in the real world? A UK cohort study evaluating the incidence of stroke in the absence of anticoagulation in atrial fibrillation (AF)
28 August 2016 (14:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker

Bristol-Myers Squibb Pharmaceuticals Limited , London (United Kingdom of Great Britain & Northern Ireland)
22 More presentations in this session
Access the full session
The Event
ESC Congress 2016
28 August 2016
14:00 CET
